News Releases

20210201-garantziotis-hyaluronan.jpg

NIH study shows hyaluronan is effective in treating chronic lung disease

February 1, 2021 — Naturally produced by the body, hyaluronan represents a new class of biologic that significantly improves lung health in patients with severe COPD.
20210129-prion-thumb.jpg

Scientists identify locations of early prion protein deposition in retina

January 29, 2021 — Findings indicate cones precede rods as targets for infection.
20210129-niaid-janssen.jpg

Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released

January 29, 2021 — Single dose vaccine appears to be safe and effective at preventing moderate and severe COVID-19 in adults.
20200128-preg-covid.jpg

Severe COVID-19 in pregnancy associated with preterm birth, other complications

January 28, 2021 — NIH-funded study also suggests mother-to-infant transmission appears to be rare.
20210128-brain.jpg

Researchers use patients’ cells to test gene therapy for rare eye disease

January 28, 2021 — Approach could provide new path for difficult-to-treat forms of Leber congenital amaurosis.
20210128-sleep.jpg

Study links neighborhood conditions to adolescent sleep loss

January 28, 2021 — Insufficient sleep decreases brain wave activity associated with cognition.
20210126-neuro-bank.jpg

NIH launches database to track neurological symptoms associated with COVID-19

January 26, 2021 — The body’s response to COVID-19 infection on the brain, spinal cord, nerves and muscle can be particularly devastating.
20210126-hiv.jpg

Antibody infusions prevent acquisition of some HIV strains, NIH studies find

January 26, 2021 — Results will inform development of long-acting antibody-based HIV prevention tools.
20210125-asprin.jpg

Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages

January 25, 2021 — NIH study examines pattern of aspirin use, rather than difference between aspirin and placebo groups.
20210122-covid.jpg

Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients

January 22, 2021 — Full doses of blood thinners, in addition to being safe, were superior to the doses normally given to prevent blood clots in hospitalized patients.

Site Menu

COVID-19 is an emerging, rapidly evolving situation.

You are here

News & Events

News Releases

20210201-garantziotis-hyaluronan.jpg

NIH study shows hyaluronan is effective in treating chronic lung disease

20210129-prion-thumb.jpg

Scientists identify locations of early prion protein deposition in retina

20210129-niaid-janssen.jpg

Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released

20200128-preg-covid.jpg

Severe COVID-19 in pregnancy associated with preterm birth, other complications

20210128-brain.jpg

Researchers use patients’ cells to test gene therapy for rare eye disease

20210128-sleep.jpg

Study links neighborhood conditions to adolescent sleep loss

20210126-neuro-bank.jpg

NIH launches database to track neurological symptoms associated with COVID-19

20210126-hiv.jpg

Antibody infusions prevent acquisition of some HIV strains, NIH studies find

20210125-asprin.jpg

Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages

20210122-covid.jpg

Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients

Pages

Connect with Us